| Schedule of Basic and Diluted Loss Per Share |
Basic
and diluted loss per share for each of the years presented were calculated as follows:
| | |
For the Years Ended December 31, | |
| | |
2023 | | |
2024 | | |
2025 | |
| | |
RMB | | |
RMB | | |
RMB | | |
US$ | |
| Numerator: | |
| | |
| | |
| | |
| |
| Net loss | |
| (36,949,421 | ) | |
| (37,365,434 | ) | |
| (130,931,921 | ) | |
| (18,723,015 | ) |
| Accretion to redemption value of mezzanine equity | |
| (108,440,354 | ) | |
| (105,969,614 | ) | |
| (81,648,716 | ) | |
| (11,675,611 | ) |
| Less: Net income attributable to noncontrolling interests | |
| 1,057 | | |
| 25,878 | | |
| (1,520 | ) | |
| (217 | ) |
| Net loss attributable to the Pomdoctor Limited’s ordinary shareholders | |
| (145,390,832 | ) | |
| (143,360,926 | ) | |
| (212,579,117 | ) | |
| (30,398,409 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted average number of shares outstanding – basic | |
| 6,310,198 | | |
| 6,310,198 | | |
| 9,680,622 | | |
| 9,680,622 | |
| Weighted average number of shares outstanding – diluted | |
| 6,310,198 | | |
| 6,310,198 | | |
| 9,680,622 | | |
| 9,680,622 | |
| | |
| | | |
| | | |
| | | |
| | |
| Loss per share – Basic: | |
| (23.04 | ) | |
| (22.72 | ) | |
| (21.96 | ) | |
| (3.14 | ) |
| | |
| | | |
| | | |
| | | |
| | |
| Loss per share – Diluted: | |
| (23.04 | ) | |
| (22.72 | ) | |
| (21.96 | ) | |
| (3.14 | ) |
|